Share This Page

Alzheimer's And Dementia Weekly

Support & Insight for the Autumn of Life

Drugs

Hong Xu, assistant professor at the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet

Aricept (Donepezil) for Dementia with Lewy Bodies

August 25, 2024 3 Comments

There are no approved treatments for DLB, though it is the second most common type of dementia. Do drugs like donepezil hold the key?

Leqembi: Pioneering Alzheimer’s Drug Faces Challenge in Europe

July 26, 2024 No Comments

While the initial headlines might seem discouraging, there’s always more to the story. 🌟

How to Choose Between Kisunla vs. Leqembi, The New Alzheimer’s Drugs

July 14, 2024 3 Comments

The newest Alzheimer’s drugs, Kisunla and Leqembi, are the first to actually slow down Alzheimer’s. How do they compare to each other?

Kisunla Approved by FDA, 2nd Drug to Actually Slow Alzheimer’s

July 5, 2024 No Comments

VIDEO + ARTICLE: Kisunla (generic name: Donanemab) slowed cognitive and functional decline 35%. Once-monthly infusions reduced Alzheimer’s plaque 84%.

Leqembi Launched in China to Fight Alzheimer’s

July 3, 2024 No Comments

China is the third country to launch LEQEMBI for sale, to fight Alzheimer’s, following the United States and Japan.

Unlocking Terazosin’s Potential for Dementia with Lewy Bodies

June 26, 2024 1 Comment

Three FDA-Approved drugs, terazosin, doxazosin, and alfuzosin, have a happy side effect; they boost energy production in brain cells. New studies suggest this slows or prevents Dementia with Lewy Bodies.

Woman caring for her mother with dementia

Getting Dementia Patients to Take Their Meds

June 25, 2024 No Comments

Grandma hates taking her medications. With her dementia, she ends up asking 10 different times why she has to take it! What should I do?

FDA Endorses Donanemab, Revolutionary Alzheimer’s Treatment

June 11, 2024 No Comments

The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer’s drug.

LEQEMBI® for Alzheimer’s Now in USA, China, Japan, South Korea

June 4, 2024 1 Comment

South Korea joined other countries in approving LEQEMBI® (generic lecanemab) for mild cognitive impairment, mild and early Alzheimer’s. Learn how Leqembi is treating Alzheimer’s around the world.

Seroquel-quetiapine Prescriptions Drop 15% After Dementia Warning

May 22, 2024 3 Comments

“People with dementia living in nursing homes and in the community were prescribed less and we did not detect negative health impacts for these groups.”

Close-up of a person elegantly opening a wine bottle beside an empty glass on a modern table.

500,000 Alcohol Drinkers: Every Level Increases Dementia Risk

October 10, 2025

The biggest-ever study of genetic and observational data now suggests no safe level of alcohol when it comes to dementia risk. Could even “light drinking” be harmful?

Experts Can Diagnose Lewy Body Dementia 18 Months Faster

October 9, 2025

MISDIAGNOSIS? Lewy Body Dementia (LBD) is often mistaken for Alzheimer’s or Parkinson’s. People typically go through 18 months and 3 doctors to get a correct diagnosis. Learn what to do about it.

Elderly businessman in a suit thoughtfully working on a laptop at his desk.

Shift Your Mindset: Purpose-in-Life Cuts Dementia Risk 28%

October 8, 2025

What if protecting your brain started not with a pill, but with a purpose? A new study finds that people with a strong sense of purpose in life are significantly less likely to develop dementia — cutting their risk by nearly one-third.

Most Popular Stories

ai generated, doctor, neurologist, laboratory, hospital, research, medical research center, brain, brain research, neurons neurons, skull, brain cells, research, research, research, research, research, brain, brain

How Do You Know If Someone Has Alzheimer’s?

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

kid, coffee, cup, breakfast, tiny, kids, small, coffee, coffee, coffee, coffee, coffee, kids

Big Cup, Little Man: Picking Up the Earliest Signs of Alzheimer’s

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

85 with Dementia? Good Chance It’s HS-AGING, Not Alzheimer’s

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?

Grandmother in black and white striped shirt hugging girl in black and white striped shirt

A Grandchild for One Day Keeps Dementia Away

An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?